The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure

被引:10
|
作者
Fu, Shihui [1 ,2 ,3 ]
Xie, Leixing [2 ,3 ]
Li, Dongyun [1 ,2 ,3 ]
Ye, Ping [1 ]
Luo, Leiming [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Beijing 100853, Peoples R China
关键词
NT-proBNP; prognosis; chronic heart failure; elderly; IMPACT; GUIDELINES; SURVIVAL;
D O I
10.2147/CIA.S77417
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: This study was conducted to research the prognostic utility of N-terminal pro-B-type natriuretic peptide (NT-proBNP), compare the utility of the Seattle Heart Failure Score (SHFS) with NT-proBNP, develop a risk-evaluation model based on NT-proBNP, assess the associations of NT-proBNP with patient characteristics, and screen for decisive factors of NT-proBNP in Chinese elderly with chronic heart failure (CHF). Patients and methods: There were 306 patients (>= 60 years) with CHF chosen as study subjects. Each one received an assessment of NT-proBNP on serum. The end point was all-cause mortality during a mean follow-up period of 471 days. Results: Subjects had a median age of 85 (60-100) years, a median NT-proBNP of 1,743.4 pg/mL, and a median SHFS of 1.87. During the follow-up period, 104 deaths occurred. NT-proBNP was significantly related to mortality (odds ratio 1.603, 95% confidence interval 1.407-1.826; P<0.001) and the significance persisted after full adjustment (odds ratio 1.282, 95% confidence interval 1.103-1.489; P=0.001). Age, New York Heart Association class IV CHF, plasma albumin, and neutrophils/lymphocytes were also independent predictors for mortality (P<0.05 for all). NT-proBNP and the SHFS showed similar predictive capacities (0.736 versus 0.796, P=0.105). The addition of NT-proBNP to the SHFS (0.818 versus 0.796, P=0.168) generated marginal growth in the c-statistic. The model based on NT-proBNP consisting of all selected predictors in this study, including age, New York Heart Association class IV CHF, plasma albumin, neutrophils/lymphocytes, and NT-proBNP, had a moderately higher c-statistic compared with the SHFS (0.846 versus 0.796, P=0.066). NT-proBNP was bound with the SHFS (r=0.500, P<0.001). Characteristics regarding general condition, inflammation, and cardiac and renal function were the decisive factors of NT-proBNP (P<0.05 for all). Conclusion: As a comprehensive representation of the patient characteristics described earlier, NT-proBNP values provided significant prognostic power similar to the SHFS in Chinese elderly with CHF. A novel model based on NT-proBNP could offer help for risk stratification.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 50 条
  • [31] Prognostic Value of Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in Adults With Congenital Heart Disease
    Baggen, Vivan J. M.
    Baart, Sara J.
    van den Bosch, Annemien E.
    Eindhoven, Jannet A.
    Witsenburg, Maarten
    Cuypers, Judith A. A. E.
    Roos-Hesselink, Jolien W.
    Boersma, Eric
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (07):
  • [32] No effect of group-based aerobic interval training on N-terminal pro-B-type natriuretic peptide levels in patients with chronic heart failure
    Nilsson, Birgitta Blakstad
    Westheim, Arne
    Risberg, May Arna
    Arnesen, Harald
    Seljeflot, Ingebjorg
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2010, 44 (04) : 223 - 229
  • [33] N-Terminal B-type Natriuretic Peptide in Heart Failure
    Richards, Arthur Mark
    HEART FAILURE CLINICS, 2018, 14 (01) : 27 - +
  • [34] Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Election Fraction
    Cunningham, Jonathan W.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Zile, Michael R.
    Anand, Inder S.
    Packer, Milton
    Zannad, Faiez
    Lam, Carolyn S. P.
    Janssens, Stefan
    Jhund, Pardeep S.
    Kober, Lars
    Rouleau, Jean
    Shah, Sanjiv J.
    Chopra, Vijay K.
    Shi, Victor C.
    Lefkowitz, Martin P.
    Prescott, Margaret F.
    Pfeffer, Marc A.
    McMurray, John J., V
    Solomon, Scott D.
    JACC-HEART FAILURE, 2020, 8 (05) : 372 - 381
  • [35] Inverse Association of N-Terminal Pro-B-Type Natriuretic Peptide with Metabolic Syndrome in Patients with Congestive Heart Failure
    Chang, Huai-Ren
    Hsieh, Jen-Che
    Hsu, Bang-Gee
    Wang, Ling-Yi
    Chen, Michael Yu-Chih
    Wang, Ji-Hung
    PLOS ONE, 2013, 8 (11):
  • [36] The minimal informative monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure
    Dai, Zhehao
    Asano, Taku
    Takahashi, Osamu
    Komiyama, Nobuyuki
    Ohde, Sachiko
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [37] N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
    Schnorbach, Johannes
    Froehlich, Hanna
    Taeger, Tobias
    Corletto, Anna
    Katus, Hugo A.
    Frankenstein, Lutz
    ESC HEART FAILURE, 2019, 6 (04): : 640 - 648
  • [38] Prognostic value of N-terminal Pro-B-Type natriuretic peptide in patients with intermediate coronary lesions
    Song, Chenxi
    Yuan, Sheng
    Cui, Kongyong
    Cai, Zhongxing
    Zhang, Rui
    He, Jining
    Qiao, Zheng
    Bian, Xiaohui
    Wu, Shaoyu
    Wang, Haoyu
    Fu, Rui
    Wang, Chunyue
    Liu, Qianqian
    Yin, Dong
    Jia, Lei
    Dou, Kefei
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [39] Prognostic utility of N-terminal pro-B-type natriuretic peptide and the modified Model for End-Stage Liver Disease in patients with end-stage heart failure
    Szczurek, Wioletta
    Szygula-Jurkiewicz, Bozena
    Zakliczynski, Michal W.
    Krol, Bogumila
    Gasior, Mariusz
    Zembala, Marian
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (04): : 235 - 243
  • [40] Plasma N-terminal pro-B-type natriuretic peptide in the detection of aortic valve stenosis
    Koljonen, Elisa
    Lappalainen, Laura
    Kotiranta, Sanna
    Turpeinen, Anu
    Vepsalainen, Ville
    Karkkainen, Satu
    Romppanen, Jarkko
    Selander, Tuomas
    Hartikainen, Juha
    Rysa, Jaana
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2023, 83 (07): : 489 - 494